These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9477174)

  • 1. Platelet activating factor antagonist activity of ginsenosides.
    Jung KY; Kim DS; Oh SR; Lee IS; Lee JJ; Park JD; Kim SI; Lee HK
    Biol Pharm Bull; 1998 Jan; 21(1):79-80. PubMed ID: 9477174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Maffrand JP
    Biochem Pharmacol; 1993 Jan; 45(1):51-8. PubMed ID: 8381007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z; Imura Y; Nishikawa K
    Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Cailleau C; Maffrand JP
    J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis.
    Yang HO; Suh DY; Han BH
    Planta Med; 1995 Feb; 61(1):37-40. PubMed ID: 7700989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding.
    Mikashima H; Takehara S; Muramoto Y; Khomaru T; Terasawa M; Tahara T; Maruyama Y
    Jpn J Pharmacol; 1987 Aug; 44(4):387-91. PubMed ID: 2890779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species difference in the specific receptors of platelet activating factor.
    Hwang SB; Lam MH
    Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of kadsurenone analogues.
    Ponpipom MM; Bugianesi RL; Brooker DR; Yue BZ; Hwang SB; Shen TY
    J Med Chem; 1987 Jan; 30(1):136-42. PubMed ID: 3027330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
    Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM; Laplace MC; Maffrand JP
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
    Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.